ncRNA name
hsa-miR-214-5p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
None
Biomarker application
Upstream regulatory factors
HCG11
Downstream target
SOX4
Cancer name
Colorectal Carcinoma
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
HLA complex group 11 is involved in colorectal carcinoma cisplatin resistance via the miR-214-5p/SOX4 axis
Tissue resource
pairs of colorectal cancer and non-cancerous tissues
primary colorectal cancer cell lines HCT116
primary colorectal cancer cell lines SW620
primary colorectal cancer cell lines SW480
primary colorectal cancer cell lines HT-29
normal colon tissue cell lines HIEC-6
Experiment
None
Institute
the First Affiliated Hospital of Yangtze University
American Type Culture Collection
Country
China
United States
Continent
Asia
North Amercian